Kevin Yeaman - Dec 17, 2021 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
President and CEO, Director
Signature
/s/ Daniel Rodriguez, Attorney-in-Fact for Kevin Yeaman
Stock symbol
DLB
Transactions as of
Dec 17, 2021
Transactions value $
-$956,881
Form type
4
Date filed
12/20/2021, 07:41 PM
Previous filing
Dec 16, 2021
Next filing
Jan 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Tax liability -$468K -5.08K -4.51% $92.00 108K Dec 17, 2021 Direct F1, F2
transaction DLB Class A Common Stock Sale -$176K -1.94K -6.02% $90.74 30.3K Dec 17, 2021 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 F3
transaction DLB Class A Common Stock Sale -$313K -3.42K -11.26% $91.69 26.9K Dec 17, 2021 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units.
F2 Shares held following the reported transactions include 107,579 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F3 This transaction was executed in multiple trades at prices ranging from $90.17 to $91.05, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F4 This transaction was executed in multiple trades at prices ranging from $91.48 to $91.88, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Remarks:

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.